Literature DB >> 19727002

Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics.

Elisabet Lönnermark1, Vanda Friman, Georg Lappas, Torsten Sandberg, Anna Berggren, Ingegerd Adlerberth.   

Abstract

GOALS: To examine if intake of Lactobacillus plantarum can prevent gastrointestinal side effects in antibiotic-treated patients.
BACKGROUND: Diarrhea is a common side effect of treatment with antibiotics. Some studies indicate that the risk of antibiotic-associated diarrhea can be reduced by administration of certain probiotic microorganisms. STUDY: Patients treated for infections at a university hospital infectious diseases clinic were randomized to daily intake of either a fruit drink with L. plantarum 299v (10(10) colony forming units/d) or a placebo drink, until a week after termination of antibiotic treatment. Subjects recorded the number and consistency of stools as well as gastrointestinal symptoms until up to 3 weeks after last intake of test drink. Fecal samples were collected before the first intake of test drink and after termination of antibiotic therapy and analyzed for Clostridium difficile toxin.
RESULTS: Clinical characteristics on admission were similar in the 2 groups. The overall risk of developing loose or watery stools was significantly lower among those receiving L. plantarum [odds ratio (OR), 0.69; 95% confidence interval (CI), 0.52-0.92; P=0.012], as was development of nausea (OR, 0.51; 95% CI, 0.30-0.85; P=0.0097). Diarrhea defined as > or =3 loose stools/24 h for > or =2 consecutive days was unaffected by the treatment (OR, 1.4; 95% CI, 0.33-6.0; P=0.86). No significant differences regarding carriage of toxin producing C. difficile were observed between the groups.
CONCLUSIONS: Our results indicate that intake of L. plantarum could have a preventive effect on milder gastrointestinal symptoms during treatment with antibiotics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19727002     DOI: 10.1097/MCG.0b013e3181b2683f

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  27 in total

Review 1.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Probiotics in the next-generation sequencing era.

Authors:  Jotham Suez; Niv Zmora; Eran Elinav
Journal:  Gut Microbes       Date:  2019-04-05

Review 3.  Lactobacillus plantarum and Its Probiotic and Food Potentialities.

Authors:  Hamza Ait Seddik; Farida Bendali; Frédérique Gancel; Ismail Fliss; Giuseppe Spano; Djamel Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

4.  Lactobacillus probiotics in the prevention of diarrhea associated with Clostridium difficile: a systematic review and Bayesian hierarchical meta-analysis.

Authors:  Alison Sinclair; Xuanqian Xie; Lama Saab; Nandini Dendukuri
Journal:  CMAJ Open       Date:  2016-11-24

5.  Safety and efficacy of Profermin® to induce remission in ulcerative colitis.

Authors:  Aleksander Krag; Hans Israelsen; Bjørn von Ryberg; Klaus K Andersen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

6.  Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection.

Authors:  Mary Hickson
Journal:  Therap Adv Gastroenterol       Date:  2011-05       Impact factor: 4.409

Review 7.  Probiotics and Disease: A Comprehensive Summary-Part 2, Commercially Produced Cultured and Fermented Foods Commonly Available in the United States.

Authors:  Emily C Parker; Crystal M Gossard; Keren E Dolan; Heather J Finley; Cathleen M Burns; Margaret G Gasta; Jessica M Pizano; Christy B Williamson; Elizabeth A Lipski
Journal:  Integr Med (Encinitas)       Date:  2016-12

Review 8.  Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Authors:  Jennifer K Spinler; Caná L Ross; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-13       Impact factor: 3.331

9.  AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders.

Authors:  Geoffrey A Preidis; Adam V Weizman; Purna C Kashyap; Rebecca L Morgan
Journal:  Gastroenterology       Date:  2020-06-09       Impact factor: 22.682

10.  Influence of exposure time on gene expression by human intestinal epithelial cells exposed to Lactobacillus acidophilus.

Authors:  Sarah O'Flaherty; Todd R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2012-05-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.